Ingalfarma announces that its product Dentoxol® has been incorporated into the GES programme of one of the most important health insurance companies in the country, in prophylaxis of oral mucositis in lung cancer.
3. DENTOXOL® ENTERS GES PROGRAMME
Comparte esta noticia
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email